Month: April 2023

Ad hoc announcement pursuant to Art. 53 LRFunding to enable immediate initiation of the COPILOT study, the first of two Phase 3 ColiFin® studies; first-patient-in expected in June 2023 Commitment structured as a mix of secured debt and subordinated debt mandatorily converting into equityALLSCHWIL, Switzerland, April 18, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced that the company has finalized a capital commitment from SPRIM Global Investments (SGI) totaling USD 4.5 million in the form of secured, interest-bearing debt with partial warrant coverage and subordinated debt mandatorily converting into equity. Proceeds from the capital commitment will enable the initiation of the Phase 3 COPILOT study, the first part of the registrational...

FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Name of exempt principal trader: Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeDechra Pharmaceuticals(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Advisor and Broker to Dechra Pharmaceuticals(d)        Date dealing undertaken: 17th April 2023(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer...

Jyske Bank expects earnings per share of DKK 65-75, corresponding to a net profit of DKK 4.3bn – 4.9bn in 2023. The interval includes one-off costs related to the integration of Handelsbanken Denmark, which are expected to amount to c. DKK 0.3bn. The upgraded outlook reflects a net profit of DKK 1,289m in the first quarter of 2023, corresponding to an increase of 51% compared with the first quarter of 2022. The increase can be attributed to the acquisition of Handelsbanken Denmark, which significantly surpasses the original expectations for 2023. The integration is progressing according to plan and the first branch mergers have been completed. Additionally, the effect from the higher level of interest rates also contributed. In the table below, an income statement as well as selected balance sheet items and key figures are shown.Core...

Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 20 April 2023 at 9 am (EET). The webinar will be held in Estonian. The webinar will be hosted by the chairman of the board Margus Rink and chief financial officer Paavo Truu, who present the unaudited financial results of the first quarter of 2023. During the webinar all attendees can ask questions. All questions will be answered after the presentation. To join the webinar, you need to register in advance via following link: https://forms.office.com/e/KDVBgm3P8P Registrants will be sent a link to the webinar and a reminder email one hour before the start of the webinar. The webinar will be recorded and published on the company’s website www.cooppank.ee and on our YouTube account. Coop Pank, based on Estonian capital,...

Oslo, 18 April 2023 – DNO ASA, the Norwegian oil and gas operator, will publish its Q1 2023 operating and interim financial results on 11 May 2023 at 07:00 (CET). A videoconference call with executive management will follow at 10:00 (CET). The Company issues below an update on production and sales volumes for the quarter as well as other key financial information that will be further discussed in the earnings call.Volumes (boepd)Gross operated production Q1 2023 Q4 2022 Q1 2022     Kurdistan 94,720 107,822 106,465     North Sea – – –       Net entitlement production Q1 2023 Q4 2022 Q1 2022     Kurdistan 22,691 25,618 26,670     North Sea 14,776 14,976 12,700       Sales Q1 2023 Q4 2022 Q1 2022     Kurdistan 22,691 25,618 26,670     North Sea 15,865 15,152 10,689       Equity...

WISeKey AI Capabilities to Increase Cybersecurity and Performance of Post-Quantum Semiconductors by Assisting in the Design and Optimization Geneva, Switzerland – April 18, 2023: WISeKey International Holding (“WISeKey”, SIX: WIHN, NASDAQ: WKEY), a leading cybersecurity, AI and IoT company, announced today that using AI capabilities to increase the performance of post-quantum semiconductors by assisting in the design and optimization of these materials. AI can be used to simulate and model the behavior of these semiconductors, which can help researchers to identify the most promising materials for use in quantum devices. Post-quantum semiconductors are an important area of research in the field of quantum computing. They offer the potential to improve the performance and security of devices that rely on quantum technologies. AI plays a...

Maxigesic® IV product 4 Rows of Maxigesic® IV at a manufacturing facilityAdditional extractable & leachable data generated by an accredited lab facility located in North America Results analyzed and evaluated by toxicological experts Potential regulatory approval for Maxigesic® IV for the US market before the end of 2023Liège, Belgium –– 18 April 2023 – 7AM CET – Non-regulated information  – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that its partner AFT Pharmaceuticals (“AFT”) has submitted a response to the Food & Drug Administration (FDA). The US regulatory body had requested this additional data while considering market approval for Maxigesic® IV, a novel, dual mode-of-action non-opioid...

OSLO, NORWAY (18 April 2023) – The annual general meeting of TGS ASA (“TGS” or the “Company”) will be held on 10 May 2023 at the Company’s offices in Askekroken 11, Oslo, Norway at 17:00 (Oslo time). Registration of attendees will begin at 16:30 CET. The notice for the annual general meeting is attached hereto (English and Norwegian), together with relevant appendices. The notice will be sent to all registered shareholders on 18 April 2023. To register your attendance, grant proxy or cast votes electronically in advance through VPS Investor Services, please copy and paste this link into your browser: https://investor.vps.no/gm/logOn.htm?token=3a5d2040eaba35bbf8ca38e0dedf344d8b8a2186&validTo=1686322800000&oppdragsId=20230329VPO5UCU0 (also available on www.tgs.com). The pin code and reference...

Amsterdam, the Netherlands – [04/18/2023] argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will present six abstracts further demonstrating its long-term commitment to the generalized myasthenia gravis (gMG) community during the 75th American Academy of Neurology (AAN) Annual Meeting, which is taking place from April 22-27, 2023 in Boston, MA. The presentations include clinical and real-world efgartigimod data that demonstrate the potential of neonatal Fc receptor (FcRn) blockade in transforming treatment for gMG and other IgG-mediated autoimmune diseases. “Our presentations at AAN will showcase the depth of evidence we are generating in support of the clinical and real-world profile of efgartigimod to address...